Trump's Tariffs on Generic Drugs Could Hit Polish Pharmaceutical Firms Hard

Donald Trump has threatened to impose high tariffs on generic drugs, which could severely impact Poland's pharmaceutical industry — one of Europe's leading producers of generics. The US is the largest trading partner for Polish pharma companies, so the tariffs could impose enormous financial strain. European producers in general would struggle to absorb the additional costs.